| NS | nephrotic syndrome |
| MCNS | minimal change nephrotic syndrome |
| FSGS | focal segmental glomerulosclerosis |
| MGN | membranous glomerulonephropathy |
| suPAR | soluble form of the urokinase receptor |
| miRNA | microRNA |
| 3′-UTR | three prime untranslated region |
| PLA2R1 | phospholipase A2 receptor 1 |
| THSD7A | thrombospondin type-1 domain-containing 7A |
| NELL-1 | neural epidermal growth factor-like 1 protein |
| TNFSF11 | TNF superfamily member 11 |
| JNK | c-Jun N-terminal kinase |
| LPS | lipopolysaccharide |
| IL-13 | interleukin 13 |
| Angptl-4 | angiopoietin-like 4 |
| uPAR | urokinase plasminogen activator receptor |
| PAN | puromycin aminonucleoside |
| TRPC1 | transient receptor potential canonical 1 |
| DN | diabetes nephropathy |
| PTEN | phosphatase and tensin homolog |
| BCL2L11 | Bcl-2-like protein 11 |
| CXCL14 | C-X-C motif chemokine ligand 14 |
| WT1 | Wilms’ tumor protein |
| TRPC6 | transient receptor potential cation channel subfamily C member 6 |
| PPP3CA | protein phosphatase 3 catalytic subunit alpha |
| PPP3CB | protein phosphatase 3 catalytic subunit beta |
| PPP3R1 | protein phosphatase 3 regulatory subunit alpha |
| NFATC3 | nuclear factor of activated T cells 3 |
| ITGB3 | integrin β3 |
| BNIP3L | BCL2 interacting protein 3 like |
| NOS | not otherwise specified |